Detection and localization of surgically resectable cancers with a multi-analyte blood test

Cited by (1,003)

Items 901–1,000 of 1,003

1. Looking for trouble? Diagnostics expanding disease and producing patients
   Bjørn Hofmann · 2018 · Journal of Evaluation in Clinical Practice
2. A review of lifestyle, metabolic risk factors, and blood‐based biomarkers for early diagnosis of pancreatic ductal adenocarcinoma
   Yuanjie Pang, Michael Vaclav Holmes, Zhengming Chen, Christiana Kartsonaki · 2018 · Journal of Gastroenterology and Hepatology
3. Helical‐Like 3D Ultrathin Piezoelectric Element for Complicated Ultrasonic Field
   Xiaoyang Chen, Xuejun Qian, Kwok Ho Lam, Chi Tat Chiu, Ruimin Chen, Zeyu Chen, Koping Kirk Shung, Ping Yu, Qifa Zhou · 2019 · Advanced Functional Materials
4. Circulating tumor cells as Trojan Horse for understanding, preventing, and treating cancer: a critical appraisal
   Alexios‐Fotios A. Mentis, Petros D. Grivas, Efthimios Dardiotis, Nicholas A. Romas, Athanasios G. Papavassiliou · 2020 · Cellular and Molecular Life Sciences
5. Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection
   Victoria El‐Khoury, Anna Schritz, Sang‐Yoon Kim, Antoine Lesur, Katriina Sertamo, François Bernardin, Konstantinos Pétritis, Patrick Pirrotte, Cheryl L. Selinsky, Jeffrey R. Whiteaker et al. · 2020 · Cancers
6. Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer
   Yoon Ming Chin, Yoko Kobayashi Takahashi, Hiu Ting Chan, Masumi Otaki, Makoto Fujishima, Tomoko Shibayama, Yoshio Miki, Takayuki Ueno, Yusuke Nakamura, Siew‐Kee Low · 2020 · Cancer Science
7. The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer
   Brad A. Davidson, Sarah Croessmann, Ben Ho Park · 2021 · British Journal of Cancer
8. A DNA methylation-based liquid biopsy for triple-negative breast cancer
   Katrina Cristall, François‐Clément Bidard, Jean‐Yves Pierga, Michael J. Rauh, Tatiana G. Popova, Clara Sebbag, Olivier J Lantz, Marc‐Henri Stern, Christopher R. Mueller · 2021 · npj Precision Oncology
9. DEEP Surveillance of Brain Cancer Using Self-Functionalized 3D Nanoprobes for Noninvasive Liquid Biopsy
   Srilakshmi Premachandran, Rupa Haldavnekar, Sunit Das, Krishnan Venkatakrishnan, Bo Tan · 2022 · ACS Nano
10. CRAG: de novo characterization of cell-free DNA fragmentation hotspots in plasma whole-genome sequencing
    Xionghui Zhou, Haizi Zheng, Hailu Fu, Kelsey Dillehay McKillip, Susan M. Pinney, Yaping Liu · 2022 · Genome Medicine
11. Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications
    Olivia Vandekerckhove, Kristof Cuppens, Karin Pat, Bert Du Pont, Guy Froyen, Brigitte Maes · 2023 · Cancers
12. Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients
    Luc Cabel, Charles Decraene, Ivan Bièche, Jean‐Yves Pierga, Mostefa Bennamoun, David Fuks, Jean‐Marc Ferraz, Marine Lefèvre, Sylvain Baulande, Virginie Bernard et al. · 2019 · Cancers
13. Cerumenogram: a new frontier in cancer diagnosis in humans
    João Marcos G. Barbosa, Naiara Zedes Pereira, Lurian Caetano David, Camilla Gabriela de Oliveira, Marina Ferraz Gontijo Soares, Melissa Ameloti Gomes Avelino, Anselmo Elcana de Oliveira, Engy Shokry, Nelson Roberto Antoniosi Filho · 2019 · Scientific Reports
14. Multi-Cancer Early Detection Tests: Current Progress and Future Perspectives
    Holli Ann Loomans-Kropp, Asad Umar, Lori M. Minasian, Paul F. Pinsky · 2022 · Cancer Epidemiology Biomarkers & Prevention
15. Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer
    Kezhong Chen, Guannan Kang, Zhihong Zhang, Analyn Lizaso, Stephan Beck, Iben Lyskjær, Olga Chervova, Bingsi Li, Haifeng Shen, Chenyang Wang et al. · 2023 · BMC Medicine
16. Towards the Clinical Implementation of Extracellular Vesicle-Based Biomarker Assays for Cancer
    Sofie Van Dorpe, Philippe Tummers, Hannelore G Denys, An Hendrix · 2023 · Clinical Chemistry
17. Aberrant fragmentomic features of circulating cell-free mitochondrial DNA as novel biomarkers for multi-cancer detection
    Liu Yang, Fan Peng, Siyuan Wang, Huanmin Jiao, Miao Dang, Kaixiang Zhou, Wenjie Guo, Shanshan Guo, Huanqin Zhang, Wenjie Song et al. · 2024 · EMBO Molecular Medicine
18. Early neoplastic lesions of the pancreas: initiation, progression, and opportunities for precancer interception
    Brian A. Pedro, Laura DeLong Wood · 2025 · Journal of Clinical Investigation
19. Precision Oncology: Current Landscape, Emerging Trends, Challenges, and Future Perspectives
    Diane Qiao, Richard C. Wang, Zhixiang Wang · 2025 · Cells
20. The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers
    Sudhir Srivastava, Paul Daniel Wagner · 2020 · Cancer Epidemiology Biomarkers & Prevention
21. Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies
    Zuzana Holesova, Lucia Krasničanová, Rami Saade, Ondrej Pös, Jaroslav Budiš, Juraj Gazdarica, Vanda Repiská, Tomáš Szemes · 2023 · Genes
22. Advances on Liquid Biopsy Analysis for Glioma Diagnosis
    Panagiotis Skouras, Mariam Markouli, Theodosis Κalamatianos, George Stranjalis, Penelope A. Korkolopoulou, Christina Piperi · 2023 · Biomedicines
23. Integrating Artificial Intelligence for Advancing Multiple-Cancer Early Detection via Serum Biomarkers: A Narrative Review
    Hsin‐Yao Wang, Wan-Ying Lin, Chenfei Zhou, Zihang Yang, Sriram Kalpana, Michael Lebowitz · 2024 · Cancers
24. Lectin-based biosensors as analytical tools for clinical oncology
    M. Luísa S. Silva · 2018 · Cancer Letters
25. Electric Field–Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment
    Wei Fang, Charles M. Strom, Jordan C. Cheng, Chien‐Chung Lin, Ching-Yun Hsu, Guy W. Soo Hoo, David Chia, Yong Kim, Feng Li, David A. Elashoff et al. · 2018 · Journal of Molecular Diagnostics
26. Early detection and therapeutics
    Władysław Januszewicz, Rebecca Claire Fitzgerald · 2019 · Molecular Oncology
27. Barcode-free next-generation sequencing error validation for ultra-rare variant detection
    Huiran Yeom, Yonghee Lee, Taehoon Ryu, Jinsung Noh, Amos Chungwon Lee, Han‐Byoel Lee, Eunji Kang, Seo Woo Song, Sunghoon Kwon · 2019 · Nature Communications
28. Early Cancer Detection from Multianalyte Blood Test Results
    Ka‐Chun Wong, Junyi Chen, Jiao Zhang, Jiecong Lin, Shankai Yan, Shxiong Zhang, Xiangtao Li, Cheng Liang, Chengbin Peng, Qiuzhen Lin et al. · 2019 · iScience
29. Development and Clinical Validation of Discriminatory Multitarget Digital Droplet PCR Assays for the Detection of Hot Spot KRAS and NRAS Mutations in Cell-Free DNA
    Saskia Hussung, Marie Follo, Rhena F. U. Klar, Sandra Michalczyk, Kornelia Fritsch, Friederike Inga Nollmann, Julian Hipp, Justus Duyster, Florian Scherer, Nikolas C. C. von Bubnoff et al. · 2020 · Journal of Molecular Diagnostics
30. Identifying the tissues-of-origin of circulating cell-free DNAs is a promising way in noninvasive diagnostics
    Xiaoqing Peng, Hong‐Dong Li, Fang‐Xiang Wu, Jianxin Wang · 2020 · Briefings in Bioinformatics
31. Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation
    Maria Farooq, James Gordon Herman · 2020 · Cancer Epidemiology Biomarkers & Prevention
32. Clinical Applications of Liquid Biopsy in Colorectal Cancer Screening: Current Challenges and Future Perspectives
    Diana Galoș, Alecsandra Gorzo, Ovidiu Bălăcescu, Daniel Genel Sur · 2022 · Cells
33. Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients
    Alfonso Alba-Bernal, Ana Godoy-Ortíz, María Emilia Domínguez-Recio, Esperanza López-López, María Elena Quirós-Ortega, Victoria Sánchez-Martín, María Dunia Roldán-Díaz, Begoña Jiménez-Rodríguez, Jesús Peralta-Linero, Estefanía Bellagarza-García et al. · 2024 · npj Breast Cancer
34. Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis
    Mahmoud Assem Hamed, Valerie C. Wasinger, Qi Wang, Peter Graham, David J. Malouf, Joseph A. Bucci, Yong Li · 2024 · Journal of Controlled Release
35. Liquid Biopsy Instrument for Ultra-Fast and Label-Free Detection of Circulating Tumor Cells
    Zhu Shu, Zhixian Zhu, Chen Ni, Zheng Zhou, Chen Yao, Dezhi Tang, Kefan Guo, Shuai Yang, Kang Liu, Zhonghua Ni et al. · 2024 · Research
36. DNA methylation markers for oral cancer detection in non- and minimally invasive samples: a systematic review
    Óscar Rapado‐González, Sofia Salta, Rafael López‐López, Rui Henrique, María Mercedes Suárez‐Cunqueiro, Cármen Jerónimo · 2024 · Clinical Epigenetics
37. Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management
    Aldo Scarpa, Francisco X. Real, Claudio Luchini · 2018 · Gut
38. Mosaic-variegated aneuploidy syndrome mutation or haploinsufficiency in Cep57 impairs tumor suppression
    Khaled Aziz, Cynthia J. Sieben, Karthik B. Jeganathan, Masakazu Hamada, Brian A. Davies, Raul O. Fierro Velasco, Nazneen Rahman, David J. Katzmann, Jan M. van Deursen · 2018 · Journal of Clinical Investigation
39. The role of circulating free DNA in the management of NSCLC
    Riziero Esposito Abate, Raffaella Pasquale, Francesca Fenizia, Anna Maria Rachiglio, Cristin Roma, Francesca Bergantino, Laura Forgione, Matilde Lambiase, Alessandra Sacco, Maria Carmela Piccirillo et al. · 2018 · Expert Review of Anticancer Therapy
40. Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling
    Florian Scherer · 2019 · Recent results in cancer research/Recent Results in Cancer Research
41. The predictive and prognostic significance of cell‐free DNA concentration in melanoma
    Renáta Váraljai, Sara Elouali, Smiths Lueong, Kilian Wistuba‐Hamprecht, Teofila Seremet, Jens Thomas Siveke, Jürgen Christian Becker, Antje Sucker, Annette Paschen, Péter Horn et al. · 2020 · Journal of the European Academy of Dermatology and Venereology
42. Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration
    Laura E. Kane, Gregory S. Mellotte, Kevin C. Conlon, Barbara Mary Ryan, Stephen G. Maher · 2021 · Cancers
43. Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer
    Jhanelle E. Gray, Jeffrey C. Thompson, Erica L. Carpenter, Ehab Elkhouly, Charu Aggarwal · 2021 · The Oncologist
44. Future Directions in Artificial Intelligence
    Babak Saboury, Michael A. Morris, Eliot L. Siegel · 2021 · Radiologic Clinics of North America
45. Comprehensive Approach to Distinguish Patients with Solid Tumors from Healthy Controls by Combining Androgen Receptor Mutation p.H875Y with Cell-Free DNA Methylation and Circulating miRNAs
    Elena Tomeva, Olivier J. Switzeny, Clemens Heitzinger, Berit Hippe, Alexander G. Haslberger · 2022 · Cancers
46. Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer
    Jie Wei Zhu, Fabian Wong, Agata Szymiczek, Gabrielle E. V. Ene, Shiyu Zhang, Taymaa May, Steven Alexander Narod, Joanne Kotsopoulos, Mohammad Reza Akbari · 2023 · International Journal of Molecular Sciences
47. Early detection of hepatocellular carcinoma via no end-repair enzymatic methylation sequencing of cell-free DNA and pre-trained neural network
    Zhenzhong Deng, Yongkun Ji, Bing Han, Zhongming Tan, Yuqi Ren, Jinghan Gao, Nan Chen, Cong Ma, Yichi Zhang, Yunhai Yao et al. · 2023 · Genome Medicine
48. Potential clinical applications of circulating cell-free DNA in ovarian cancer patients
    Ana Paula Fernandes Barbosa, Ana Peixoto, Pedro Pinto, Manuela Pinheiro, Manuel Rodrigues Teixeira · 2018 · Expert Reviews in Molecular Medicine
49. Hollow Core Inhibited Coupling Fibers for Biological Optical Sensing
    Fabio Giovanardi, Annamaria Cucinotta, Andrea Rozzi, Roberto Corradini, Fetah Benabid, Lorenzo Rosa, Luca Vincetti · 2019 · Journal of Lightwave Technology
50. Amplification-Free, High-Throughput Nanoplasmonic Quantification of Circulating MicroRNAs in Unprocessed Plasma Microsamples for Earlier Pancreatic Cancer Detection
    Adrianna N. Masterson, Nayela N. Chowdhury, Yue Fang, Michele Yip-Schneider, Sumon Hati, Prashant Gupta, Sha Cao, Huangbing Wu, Christian Max Schmidt, Melissa L. Fishel et al. · 2023 · ACS Sensors
51. Zwitterionic microgel preservation platform for circulating tumor cells in whole blood specimen
    Yiming Ma, Jun Zhang, Yunqing Tian, Yihao Fu, Shu Tian, Qingsi Li, Jing Yang, Lei Zhang · 2023 · Nature Communications
52. Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer
    Chiara Reina, Berina Šabanović, Chiara Lazzari, Vanesa Gregorc, Christopher Heeschen · 2024 · Translational research
53. Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology
    Wan Ying Tan, Snigdha Nagabhyrava, Olivia Ang-Olson, Paromita Das, Luisa Ladel, Bethsebie Sailo, Linda He, Anup R. Sharma, Nita Ahuja · 2024 · Current Issues in Molecular Biology
54. GBM immunotherapy: Exploring molecular and clinical frontiers
    Mrinal K. Ghosh, Sunny Kumar, Sabana Begam, Sayani Ghosh, Malini Basu · 2024 · Life Sciences
55. Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications
    Jae‐Ho Park, Yi‐Te Lee, Vatche Garen Agopian, Jessica S Liu, Ekaterina K. Koltsova, Sungyong You, Yazhen Zhu, Hsian‐Rong Tseng, Ju Dong Yang · 2024 · Clinical and Molecular Hepatology
56. Plasmonic coffee-ring biosensing for AI-assisted point-of-care diagnostics
    Kamyar Behrouzi, Zahra Khodabakhshi Fard, Chunming Chen, Peisheng He, Megan Teng, Liwei Lin · 2025 · Nature Communications
57. Liquid biopsy in newly diagnosed patients with locoregional (I-IIIA) non-small cell lung cancer
    Kezhong Chen, Guannan Kang, Heng Zhao, Kai Zhang, Jian Zhang, Fan Yang, Jun Wang · 2019 · Expert Review of Molecular Diagnostics
58. Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
    ChongFeng Gao, Luke Wisniewski, Ying Liu, Ben Staal, Ian Beddows, Dennis Plenker, Mohammed Aldakkak, Johnathan Hall, Daniel Barnett, Mirna Kheir Gouda et al. · 2020 · Clinical Cancer Research
59. 5‐Hydroxymethylcytosine signature in circulating cell‐free DNA as a potential diagnostic factor for early‐stage colorectal cancer and precancerous adenoma
    Zewen Xiao, Wendy Yi-Ying Wu, Chunlong Wu, Man Li, Fu-Ming Sun, Lu Zheng, Gao-Jing Liu, Xiaoling Li, Zhiyuan Yun, Jiebing Tang et al. · 2020 · Molecular Oncology
60. Blood-Based Liquid Biopsy for Comprehensive Cancer Genomic Profiling Using Next-Generation Sequencing: An Emerging Paradigm for Non-invasive Cancer Detection and Management in Dogs
    Kristina M. Kruglyak, Jason Chibuk, Lisa M. McLennan, Prachi Nakashe, Gilberto E. Hernandez, Rita Motalli-Pepio, Donna M. Fath, John A. Tynan, Lauren E. Holtvoigt, Ilya Chorny et al. · 2021 · Frontiers in Veterinary Science
61. Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
    Ke Ye, Qinqiao Fan, Mingming Yuan, Dong Wang, Xiao Liang, Guo Long, Rongrong Chen, Tongdi Fang, Zengbo Li, Ledu Zhou · 2022 · Frontiers in Oncology
62. Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients
    Florian Janke, Arlou Kristina Angeles, Anja Lisa Riediger, Simone Bauer, Martin Reck, Albrecht Stenzinger, Marc Andre Schneider, Thomas Muley, Michael Thomas, Petros Christopoulos et al. · 2022 · Clinical Epigenetics
63. Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes
    Fanyu Meng, Wenjun Yu, Minjia Niu, Xiaoting Tian, Yayou Miao, Xvelian Li, Yan Zhou, Lifang Ma, Xiao Zhang, Kun Qian et al. · 2023 · Journal of Nanobiotechnology
64. Early Detection of Lung Cancer Using Small RNAs
    Tobias Sikosek, Rastislav Horos, Franziska Christina Trudzinski, Julia Jehn, Maurice Frank, Timothy Rajakumar, Laura Valentina Klotz, Nathaniel David Mercaldo, Mustafa Kahraman, Marco Heuvelman et al. · 2023 · Journal of Thoracic Oncology
65. Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy
    Kerstin Zwirner, Franz J. Hilke, German M. Demidov, Stephan Ossowski, Cihan Gani, Olaf Rieß, Daniel Zips, Stefan Welz, Christopher Schroeder · 2018 · Radiotherapy and Oncology
66. The use of cell free DNA in the diagnosis of HCC
    Bubu A. Banini, Arun Jayant Sanyal · 2019 · Hepatoma Research
67. Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
    Matteo Allegretti, Giuliano Cottone, Fabio Carboni, Ettore Cotroneo, Beatrice Casini, Elena Giordani, Carla Azzurra Amoreo, Simonetta Buglioni, Maria Grazia Diodoro, Edoardo O. Pescarmona et al. · 2020 · Journal of Experimental & Clinical Cancer Research
68. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers
    Song, Guodong, Wang, Li, Tang, Junlong, Li, Haohui, Pang, Shuyu, Li, Yan, Liu, Li, Hu, Junyuan · 2023 · Metabolomics
69. Interval Breast Cancers Versus Screen Detected Breast Cancers: A Retrospective Cohort Study
    Emily B. Ambinder, Emerson E. Lee, Derek L. Nguyen, Anna J. Gong, Orli J. Haken, Kala Visvanathan · 2023 · Academic Radiology
70. Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment
    Aparna R. Parikh, Bryant H. Chee, Jill Tsai, Thereasa A. Rich, Kristin Sedgwick Price, Sonia A. Patel, Li Zhang, Faaiz Ibrahim, Mikaela Esquivel, Emily E. Van Seventer et al. · 2024 · Clinical Cancer Research
71. Liquid biopsy in gynecological cancers: a translational framework from molecular insights to precision oncology and clinical practice
    Canio Vito Martinelli, Alfredo Ercoli, Giuseppe Vizzielli, Sharon Raffaella Burk, Maria Cuomo, Vrunda Satasiya, Housem Kacem, Simone Braccia, Giulio Mazzarotti, Irene Miriello et al. · 2025 · Journal of Experimental & Clinical Cancer Research
72. Unravelling the Diagnostic Dilemma: A MicroRNA Panel of Circulating MiR-16 and MiR-877 as A Diagnostic Classifier for Distal Bile Duct Tumors
    Laura L. Meijer, Jisce R. Puik, Tessa Y. S. Le Large, Michal Heger, Frederike Dijk, Niccola Funel, Thomas Würdinger, Ingrid Garajová, Nicole C.T. van Grieken, Mark A. van de Wiel et al. · 2019 · Cancers
73. Donor-specific cell-free DNA as a biomarker in liver transplantation: A review
    Tess McClure, Su Kah Goh, Daniel R A Cox, Vijayaragavan Muralidharan, Alexander Dobrovic, Adam Testro · 2020 · World Journal of Transplantation
74. Current Trends in Cell-Free DNA Applications. Scoping Review of Clinical Trials
    Robert S. Stawski, Emilia Stec‐Martyna, Adam Chmielecki, Dariusz Nowak, Ewelina Perdas · 2021 · Biology
75. Liquid biopsies in pediatric oncology: opportunities and obstacles
    R. Taylor Sundby, Alexander C. Pan, Jack F. Shern · 2021 · Current Opinion in Pediatrics
76. Multicancer early detection test: Preclinical, translational, and clinical evidence–generation plan and provocative questions
    John B. Kisiel, Nickolas Papadopoulos, MC Liu, David L. Crosby, Sudhir Srivastava, Ernest T. Hawk · 2022 · Cancer
77. Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
    Shruti Jain, Nimrah Nadeem, Benjamin Ulfenborg, Maria Mäkelä, Shamima Afrin Ruma, Joonas Terävä, Kaisa Huhtinen, Janne Leivo, Björg Kristjánsdóttir, Kim S. I. Pettersson et al. · 2022 · International Journal of Cancer
78. Exosomes from prostate cancer cell lines: Isolation optimisation and characterisation
    Anikó Bertóková, Natalia Svecova, Katarína Kozics, Alena Gábelová, Alica Vikartovská, Eduard Jáné, Michal Híreš, Tomáš Bertók, Jan Tkáč · 2022 · Biomedicine & Pharmacotherapy
79. Extracellular Vesicle–Based Multianalyte Liquid Biopsy as a Diagnostic for Cancer
    Andrew A. Lin, Vivek U. Nimgaonkar, David Issadore, Erica L. Carpenter · 2022 · Annual Review of Biomedical Data Science
80. The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
    Ugur Deligezer, Abel Jacobus Bronkhorst, Stefan Holdenrieder · 2022 · Diagnostics
81. Rationally designed far-red emitting styryl chromones and a magnetic nanoconjugate for strip-based ‘on-site’ detection of metabolic markers
    P. Kavyashree, Barsha Chakraborty, Varsha Rani, Apurba Lal Koner · 2022 · Journal of Materials Chemistry B
82. Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
    Samaneh Eickelschulte, Anja Lisa Riediger, Arlou Kristina Angeles, Florian Janke, Stefan M. Duensing, Holger Sültmann, Magdalena Görtz · 2022 · Cancers
83. Frontiers in mass spectrometry–based clinical proteomics for cancer diagnosis and treatment
    Yoshimi Haga, Yuriko Minegishi, Koji Ueda · 2023 · Cancer Science
84. The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
    Corinna Keup, Rainer Kimmig, Sabine Kasimir‐Bauer · 2023 · Cancers
85. Opportunities in biotechnology
    Kevan M.A. Gartland, Jill S. Gartland · 2018 · Journal of Biotechnology
86. Thermopneumatic suction integrated microfluidic blood analysis system
    Chiao-Hsun Yang, Yu-Ling Hsieh, Ping‐Hsien Tsou, Bor‐Ran Li · 2019 · PLoS ONE
87. A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer
    Jin Song, Shiyong Ma, Lori J. Sokoll, Rodrigo Vargas Eguez, Naseruddin Höti, Hui Zhang, Phaedre Mohr, Renu Dua, Dattatraya Hari Patil, Kristen Douglas May et al. · 2021 · Theranostics
88. Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
    Jodie Wong, Rohit Muralidhar, Liang Wang, Chiang‐Ching Huang · 2024 · Biomedical Journal
89. Cancer and Aging Biomarkers: Classification, Early Detection Technologies and Emerging Research Trends
    Mi‐Ran Ki, Dong Hyun Kim, Mohamed A. A. Abdelhamid, Seung Pil Pack · 2025 · Biosensors
90. Next-Generation Novel Noninvasive Cancer Molecular Diagnostics Platforms Beyond Tissues
    Xiaoliang Wu, Lin Zhu, Patrick C. Ma · 2018 · American Society of Clinical Oncology Educational Book
91. Dynamic genome and transcriptional network‐based biomarkers and drugs: precision in breast cancer therapy
    Ioannis D Kyrochristos, Dimosthenis E. Ziogas, Dimitrios H Roukos · 2018 · Medicinal Research Reviews
92. Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer
    Ioannis D Kyrochristos, Dimosthenis E. Ziogas, ANNA C. GOUSSIA, Georgios K. Glantzounis, Dimitrios H Roukos · 2019 · Cancers
93. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results
    Kamlesh Gidwani, Henna Kekki, Joonas Terävä, Tero Soukka, Karin Sundfeldt, Kim S. I. Pettersson · 2019 · Molecular Aspects of Medicine
94. Role of Next-Generation Sequencing Technologies in Personalized Medicine
    Stefania Morganti, Paolo Tarantino, Emanuela Ferraro, Paolo D’Amico, Giulia Viale, Dario Trapani, Bruno Achutti Duso, Giuseppe Curigliano · 2019 · Springer eBooks
95. Predicting health and life span with the deep plasma proteome
    Valur Emilsson, Vilmundur G. Gudnason, Lori L. Jennings · 2019 · Nature Medicine
96. Cancer Genomics in Precision Oncology: Applications, Challenges, and Prospects
    Michele Araújo Pereira, Marianna Kunrath‐Lima, Patrícia Gonçalves Pereira Couto, Michele Groenner Penna, Luige Biciati Alvim, Thaís Furtado Nani, Maíra Cristina Menezes Freire, Luiz Henrique Araujo · 2020 · Springer eBooks
97. Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients
    Weixiong Yang, Na You, Minghan Jia, Sai‐Ching J. Yeung, Wei Ou, Man Yu, Yinguang Wang, Xiayu Fu, Zhanfei Zhang, Jiali Yang et al. · 2020 · Lung Cancer
98. Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
    Tomáš Bertók, Eduard Jáné, Anikó Bertóková, Lenka Lorencová, Peter Zvara, Božena Smolková, Radek Kučera, Helmut Klocker, Jan Tkáč · 2020 · Cancers
99. Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes
    Kirby P. Gardner, Mohammed Aldakkak, Cha‐Mei Tang, Susan Tsai, Daniel L. Adams · 2021 · npj Precision Oncology
100. Noninvasive early diagnosis of intestinal diseases based on artificial intelligence in genomics and microbiome
     Weitong Zhang, Xingjian Chen, Ka‐Chun Wong · 2021 · Journal of Gastroenterology and Hepatology